CS logo
small CS logo
UCLA Cancer Center

Westlake Village, California, United States
Cancer treatment center in Thousand Oaks, California
1250 La Venta Dr Suites 112, 200 & 202, Westlake Village, CA 91361

About UCLA Cancer Center


"Visit the UCLA Health website for coronavirus updates."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at UCLA Cancer Center


During the past decade, UCLA Cancer Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 7 clinical trials were completed, i.e. on average, 700% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Cancer Center" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at UCLA Cancer Center


According to Clinical.Site data, the most researched conditions in "UCLA Cancer Center" are "Breast Neoplasms" (1 trials), "Carcinoma Non-small Cell Lung Cancer Stage IIIA" (1 trials), "Carcinoma Non-small Cell Lung Cancer Stage IIIB" (1 trials), "Carcinoma Non-small Cell Lung Cancer Stage IV" (1 trials) and "Low-grade Serous Fallopian Tube Cancer" (1 trials). Many other conditions were trialed in "UCLA Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at UCLA Cancer Center


Most popular intervention types in "UCLA Cancer Center" are "Drug" (7 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Active Comparator (erlotinib)" (1 trials), "Alclometasone cream" (1 trials), "Bevacizumab" (1 trials) and "Dacomitinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at UCLA Cancer Center


The vast majority of trials in "UCLA Cancer Center" are 5 trials for "All" genders and 3 trials for "Female" genders.

Clinical Trials Status at UCLA Cancer Center


Currently, there are NaN active trials in "UCLA Cancer Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in UCLA Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in UCLA Cancer Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".